The Albert B. Sabin Vaccine Institute Inc, with EIN 06-1389829, is dedicated to making vaccines more accessible, fostering innovation, and expanding immunization efforts globally. In the 2024 filing year, the organization operates with a budget of $37.5 million and reported total revenue of $35.9 million, supported by significant funding from various sources. The organization does not rely on a single funder for 50% or more of its revenue, ensuring a diversified financial base for its mission. For more information, visit their website at www.sabin.org.